HRTX

Heron Therapeutics (HRTX)

About Heron Therapeutics (HRTX)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Details

Daily high

$0.89

Daily low

$0.84

Price at open

$0.86

52 Week High

$2.30

52 Week Low

$0.74

Market cap

162.7M

Dividend yield

0.00%

Volume

493,949

Avg. volume

2.7M

P/E ratio

-4.87

Heron Therapeutics News